A fourth dimension in decision making in hepatology

Area of Science:

• Hepatology
• Medical Diagnostics
• Biochemistry

Background:

• Current liver function tests (biopsy, blood tests) often lack sensitivity for timely patient follow-up.
• Accurate liver function assessment is crucial for prognosis and treatment decisions in liver disease.
• Existing methods provide only indirect evidence of hepatic impairment.

Purpose of the Study:

• To review the utility of the point-of-care (13)C methacetin breath test (MBT) for assessing hepatic functional reserve.
• To highlight the MBT's role in clinical decision-making for liver disease management.
• To present treatment algorithms informed by MBT results.

Main Methods:

• Utilizes the liver-specific metabolism of (13)C-labeled methacetin.
• Employs molecular correlation spectroscopy to measure exhaled (13)C.
• Focuses on a rapid, non-invasive, point-of-care breath test approach.

Main Results:

• The (13)C MBT accurately assesses liver metabolic function.
• Demonstrates the test's ability to evaluate hepatic functional reserve in acute and chronic liver disease.
• Provides a sensitive measure for patient follow-up and treatment guidance.

Conclusions:

• The (13)C MBT is a valuable tool for bedside decision-making in clinical hepatology.
• Enables precise assessment of liver function, aiding in prognosis and treatment planning.
• Facilitates timely interventions for patients with liver disorders.